Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 04/08/2011
PIL Rapamune 1mg/ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 22/07/2011 and displayed until 04/08/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 08/04/2011 and displayed until 22/07/2011
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 11/02/2011 and displayed until 08/04/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change of inactive ingredient
  • Change to packaging
  • Change to storage instructions
Updated on 16/09/2010 and displayed until 11/02/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Individual presentations superseded by joint PIL
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to storage instructions
Updated on 22/07/2010 and displayed until 16/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 29/01/2010 and displayed until 22/07/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 18/05/2009 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 11/05/2009 and displayed until 18/05/2009
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 11/03/2009 and displayed until 11/05/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/11/2008 and displayed until 11/03/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 07/12/2007 and displayed until 24/11/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to side-effects
  • Change to how to administer the medicine
  • Change to information about pregnancy or lactation
  • Change to storage instructions
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • PIL Retired pending re-submission
Updated on 05/09/2007 and displayed until 07/12/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/08/2007 and displayed until 05/09/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
Updated on 19/04/2007 and displayed until 16/08/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
Updated on 21/09/2006 and displayed until 19/04/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change of manufacturer
Updated on 25/07/2006 and displayed until 21/09/2006
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change of manufacturer
  • Change to date of revision
Updated on 19/05/2006 and displayed until 25/07/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/03/2006 and displayed until 19/05/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 16/02/2006 and displayed until 24/03/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 30/01/2006 and displayed until 16/02/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/09/2005 and displayed until 30/01/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to how to administer the medicine
  • Change to side-effects
Updated on 13/09/2004 and displayed until 26/09/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/05/2003 and displayed until 13/09/2004
Reasons for adding or updating:
  • New PIL for new product
Updated on 19/03/2003 and displayed until 15/05/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   sirolimus